Connection

Paolo Gisondi to Adalimumab

This is a "connection" page, showing publications Paolo Gisondi has written about Adalimumab.
Connection Strength

0.284
  1. Hidradenitis suppurativa and adalimumab in the COVID-19 era. Eur J Dermatol. 2020 Dec 01; 30(6):748-749.
    View in: PubMed
    Score: 0.161
  2. Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature. J Eur Acad Dermatol Venereol. 2017 Nov; 31(11):1853-1859.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.